Exchange: NYSE·Updated 04:10 AM EDT
NVS logo

NVS Novartis AG

$158.85
$6.79
(4.46%)
Pre-Market
Prev Close $152.06
EarningsOct 27
Mkt Cap$278.35B
Vol6,483.00

About NVS

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
49

Neutral Sentiment

How do you feel about NVS?

Advertisement|Remove ads.